http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png
CP-GEP Identifies High-Risk T1a Melanoma Patients Beyond Established Adverse Features.
Yu, W. Y. ; Pazhava, A. ; Weitemeyer, M. B. ; Hölmich, L. R. ; Johansson, I. ; Bagge, R. O. ; Utikal, J.DKFZ* ; Venna, S. ; Jackson, J. ; Amaral, T. ; van Akkooi, A. ; Kolodney, M. S. ; McArthur, G. A. ; Meves, A.
2025
Elsevier
Amsterdam [u.a.]
Keyword(s): CP-GEP ; Merlin Assay ; melanoma ; metastasis ; risk prediction ; sentinel lymph node biopsy
Note: epub
Contributing Institute(s):
- KKE Dermatoonkologie (A370)
Research Program(s):
- 311 - Zellbiologie und Tumorbiologie (POF4-311) (POF4-311)
Appears in the scientific report
2025
Database coverage:
; Clarivate Analytics Master Journal List ; Current Contents - Clinical Medicine ; Current Contents - Life Sciences ; Essential Science Indicators ; IF >= 10 ; JCR ; Nationallizenz

; SCOPUS ; Science Citation Index Expanded ; Web of Science Core Collection